Eligibility for Icosapent ethyl in patients undergoing cardiac rehabilitation: A real-world cohort study
{{output}}
Introduction: Despite optimal lipid-lowering therapy, many patients with established cardiovascular disease (CVD) maintain elevated triglyceride (TG) levels, contributing to residual risk. Icosapent ethyl (IPE) has shown clinical... ...
